Author details

Full Name

Bianca R MothÃ©

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
28725512	Strengthening STEM Education through Community Partnerships.		2016
26526557	The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.	Tuberculosis (Edinb)	2015
23417323	Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.	Immunogenetics	2013
23566283	CD4(+) T-cell inhibitory ligands: a tool for characterizing dysfunctional CD4(+) T cells during chronic infection.	Immunology	2013
22322672	A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules.	Immunogenetics	2012
22278177	Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1082:01 (Mane A0301).	Immunogenetics	2012
21781132	SIV-infected Chinese-origin rhesus macaques express specific MHC class I alleles in either elite controllers or normal progressors.	J Med Primatol	2011
21274527	Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A102601 and Mamu-B08301 reveals HLA-A2 and HLA-A3 supertypic specificities.	Immunogenetics	2011
20508245	Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.	Microbiol Mol Biol Rev	2010
20480161	The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype.	Immunogenetics	2010
19531389	Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.	Vaccine	2009
18829752	Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.	J Virol	2008
18389056	A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach.	PLoS Comput Biol	2008
18385228	Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.	J Virol	2008
17288609	Protein sequence database for pathogenic arenaviruses.	Immunome Res	2007
17617598	Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes.	J Immunol	2007
16772368	T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.	Int Immunol	2006
16912286	Identification of protective Lassa virus epitopes that are restricted by HLA-A2.	J Virol	2006
16439000	DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued.	Virology	2006
15795285	The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.	J Virol	2005
16148104	Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.	J Immunol	2005
15868141	Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.	Immunogenetics	2005
15971954	Development of a new vaccine for the prevention of Lassa fever.	PLoS Medicine	2005
15749848	Rationally engineered therapeutic proteins with reduced immunogenicity.	J Immunol	2005
16137805	A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules.	Vaccine	2005
15747117	Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.	Immunogenetics	2005
14966520	Reversion of CTL escape-variant immunodeficiency viruses in vivo.	Nat Med	2004
15470050	Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.	J Immunol	2004
15194783	Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.	J Virol	2004
12885919	Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.	J Virol	2003
12552014	Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.	Journal of Virology	2003
11984594	Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.	Nature Medicine	2002
12239328	Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.	J Virol	2002
11907251	Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication.	J Virol	2002
12077247	Characterization of the peptide-binding specificity of Mamu-B17 and identification of Mamu-B17-restricted epitopes derived from simian immunodeficiency virus proteins.	J Immunol	2002
11752176	Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.	J Virol	2002
11134287	CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.	J Virol	2001
10779808	Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.	J Immunol	2000
11014195	Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.	Nature	2000
11086077	Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins.	J Immunol	2000